ROYAL BANK OF CANADA - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 57 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.9%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$222,000
+54.2%
10,813
+49.5%
0.00%
Q2 2023$144,000
-92.0%
7,234
-93.1%
0.00%
Q1 2023$1,795,000
+784.2%
104,765
+909.0%
0.00%
Q4 2022$203,000
+2155.6%
10,383
+1848.0%
0.00%
Q3 2022$9,000
-96.5%
533
-97.2%
0.00%
Q2 2022$259,000
+547.5%
18,829
+643.3%
0.00%
Q1 2022$40,000
-79.5%
2,533
-71.7%
0.00%
Q4 2021$195,000
+91.2%
8,941
+162.3%
0.00%
Q3 2021$102,000
-15.0%
3,409
+25.3%
0.00%
Q2 2021$120,000
-92.5%
2,720
-92.4%
0.00%
Q1 2021$1,592,000
+19800.0%
35,886
+26286.8%
0.00%
Q4 2020$8,000
+300.0%
136
-9.3%
0.00%
Q1 2020$2,000
-92.3%
150
-86.7%
0.00%
Q4 2019$26,000
+62.5%
1,124
+77.0%
0.00%
Q3 2018$16,000
-52.9%
635
-63.5%
0.00%
Q2 2018$34,000
-24.4%
1,741
-27.3%
0.00%
Q1 2018$45,0002,3940.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders